Datril Essay

2048 Words9 Pages
GROUP 1 DATRIL CASE STUDY PROBLEM RECOGNITION. A non-prescription acetaminophen drug branded as Datril is to be launched in the spring of 1975. Bristol-Myer’s goal is that with Datril, it would be able to solidify its position in the analgesic market and gain market share in the rapidly growing acetaminophen market. The key issues are: (1) how to position Datril to the general public; (2) how to price and promote Datril; (3) Impact of Datril launch on Bristol-Myers existing aspirin based drugs, Bufferin and Excedrin, in the analgesic market; and (4) the possible competitive response from the market leader in acetaminophen drug Tylenol, by McNeil Labs, in defending their dominant position. OPTION LISTING. The crux of the options lies in how to differentiate Datril from Tylenol in the eyes of the customers. There are 2 broad strategies: 1. Option 1: Datril as a Premium Drug. This option essentially positions Datril as a premium analgesic drug with better efficacy but with less side effects than aspirin. This positions Datril as a direct competitor to the more-established Tylenol. Product differentiation should be achieved by: (1) leveraging on Bristol-Myers’ name and existing brands in the analgesic market; (2) perceived edge in efficacy of Datril over Tylenol being a newer drug; and (3) leveraging on other channels of distribution not exploited by Tylenol. Together with Bristol-Myers aspirin brands, this would form a vertical brand extension with Datril as the upscale brand. 2. Option 2: Datril as a Low-Priced Alternative to Tylenol. This option is essentially a price differentiation strategy, by positioning Datril is a cheaper alternative to Tylenol. Market growth would come from (1) attracting current aspirin users to Datril, which 1 GROUP 1 could hurt Bristol-Myers aspirin brands in the short run;

More about Datril Essay

Open Document